These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24411852)

  • 1. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
    Kaplan SA
    J Urol; 2014 Feb; 191(2):359. PubMed ID: 24411852
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
    Seftel AD
    J Urol; 2014 Feb; 191(2):359. PubMed ID: 24411851
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: long-term survival of participants in the Prostate Cancer Prevention Trial.
    Taneja SS
    J Urol; 2014 Feb; 191(2):358. PubMed ID: 24411850
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival in the prostate cancer prevention trial.
    Revannasiddaiah S; Susheela SP
    N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224634
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival in the prostate cancer prevention trial.
    Walsh PC
    N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of prostate cancer. Long-term results of the Prostate Cancer Prevention Trial (PCPT)].
    Michel MS; Nitschmann S; von Hardenberg J
    Internist (Berl); 2014 Aug; 55(8):981-2. PubMed ID: 25027005
    [No Abstract]   [Full Text] [Related]  

  • 7. A role for finasteride in the prevention of prostate cancer?
    LeFevre M
    N Engl J Med; 2013 Aug; 369(7):670-1. PubMed ID: 23944306
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival in the prostate cancer prevention trial.
    Tangen CM; Goodman PJ; Thompson IM
    N Engl J Med; 2013 Nov; 369(20):1968. PubMed ID: 24224632
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer prevention with 5 alpha-reductase inhibitors.
    Parekh DJ
    Recent Results Cancer Res; 2011; 188():109-14. PubMed ID: 21253793
    [No Abstract]   [Full Text] [Related]  

  • 10. Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.
    Barton MK
    CA Cancer J Clin; 2011; 61(1):1-2. PubMed ID: 21199914
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer: mortality unaffected by finasteride treatment.
    Payton S
    Nat Rev Urol; 2013 Oct; 10(10):551. PubMed ID: 24018566
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Long-term survival of participants in the Prostate Cancer Prevention Trial.
    Thompson IM; Tangen CM; Goodman PJ
    Asian J Androl; 2014; 16(3):414. PubMed ID: 24914438
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
    Unger JM; Till C; Thompson IM; Tangen CM; Goodman PJ; Wright JD; Barlow WE; Ramsey SD; Minasian LM; Hershman DL
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27565902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Effects of Finasteride on Prostate Cancer Mortality.
    Goodman PJ; Tangen CM; Darke AK; Lucia MS; Ford LG; Minasian LM; Parnes HL; LeBlanc ML; Thompson IM
    N Engl J Med; 2019 Jan; 380(4):393-394. PubMed ID: 30673548
    [No Abstract]   [Full Text] [Related]  

  • 15. The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.
    Theoret MR; Ning YM; Zhang JJ; Justice R; Keegan P; Pazdur R
    N Engl J Med; 2011 Jul; 365(2):97-9. PubMed ID: 21675880
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term survival of participants in the prostate cancer prevention trial.
    Thompson IM; Goodman PJ; Tangen CM; Parnes HL; Minasian LM; Godley PA; Lucia MS; Ford LG
    N Engl J Med; 2013 Aug; 369(7):603-10. PubMed ID: 23944298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of participants in the prostate cancer prevention trial.
    Silberstein JL; Sartor O
    Asian J Androl; 2014; 16(3):413-4. PubMed ID: 24625877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Traish AM; Morgentaler A
    J Steroid Biochem Mol Biol; 2013 Nov; 138():462. PubMed ID: 23851167
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of prostate cancer with finasteride.
    Schwartz DT
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562808
    [No Abstract]   [Full Text] [Related]  

  • 20. Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.
    Reddy GK
    Clin Prostate Cancer; 2004 Mar; 2(4):206-8. PubMed ID: 15072601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.